Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (HIE).

NCT02264808 is registered in ClinicalTrials.gov with University of Florida as lead sponsor.

NCT NCT02264808
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02264808 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Utility of Serum Biomarkers for the Management of Neonatal Hypoxic Ischemic Encephalopathy (HIE).
Lead sponsor
University of Florida
Phase
Observational
Overall status
Completed
Start date
November 30, 2014
Completion date
December 3, 2018
Enrollment
21 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hypoxic-ischemic encephalopathy